Salvatore De Simone | Vaccines-Pertussis toxin | Excellence in Research

Excellence in Research

Salvatore De Simone
Oswaldo Cruz Foundation

Salvatore De Simone
Affiliation Oswaldo Cruz Foundation
Country Brazil
Scopus ID 7003443244
Documents 97
Citations 1673
h-index 23
Subject Area Vaccines-Pertussis toxin
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-2172-656X

Salvatore De Simone is a researcher affiliated with the Oswaldo Cruz Foundation in Brazil whose scientific activities have contributed to studies involving infectious diseases, immunology, vaccine-related investigations, and molecular approaches relevant to public health. His publication record, citation performance, and sustained scholarly output reflect continued engagement with internationally relevant biomedical research topics. The recognition of research excellence within the field of Vaccines-Pertussis toxin highlights the importance of advancing scientific understanding of vaccine development, pathogen-host interactions, and translational applications in disease prevention.[1]

Abstract

This article presents an academic overview of Salvatore De Simone and his research activities associated with infectious diseases and vaccine-related investigations. His scientific contributions support the advancement of biomedical knowledge through multidisciplinary approaches involving molecular biology, immunology, pathogen characterization, and translational research. Particular attention is given to scientific themes connected with Vaccines-Pertussis toxin, where understanding immune responses and vaccine effectiveness remains essential for disease prevention strategies. The researcher’s publication profile, citation performance, and documented scholarly impact illustrate sustained engagement with internationally recognized research efforts and collaborative scientific advancement.[1]

Keywords

Vaccines, Pertussis Toxin, Infectious Diseases, Immunology, Public Health, Biomedical Research, Molecular Biology, Translational Medicine, Vaccine Development, Scientific Impact.

Introduction

The study of infectious diseases continues to represent a major area of scientific inquiry due to the ongoing emergence of pathogens and the need for effective preventive interventions. Research focused on vaccines and associated biological mechanisms plays an essential role in improving population health outcomes. Investigations involving pertussis toxin and vaccine-associated immune responses contribute to understanding pathogen virulence, immunogenicity, and long-term protection.[2]

Research Profile

Salvatore De Simone has developed a research profile characterized by interdisciplinary scientific investigations addressing biological systems relevant to infectious diseases. Bibliometric indicators including publication volume, citation count, and h-index demonstrate measurable scholarly engagement and continuing influence across multiple research communities.[1]

Research Contributions

Research contributions associated with Salvatore De Simone encompass investigations relevant to infectious disease biology, molecular mechanisms, immunological responses, and vaccine-related scientific questions. Contributions within vaccine science and studies connected to pertussis toxin provide valuable perspectives regarding antigenic properties, immune modulation, and mechanisms that influence vaccine efficacy and safety.[2]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles contributing to knowledge within infectious disease research and related biomedical disciplines. The documented publication output indicates sustained scientific productivity and participation in scholarly communication through internationally indexed journals. Citation metrics suggest that published findings have informed subsequent investigations and supported broader scientific discourse.[1]

Research Impact

Research impact may be evaluated through publication influence, citation performance, scientific visibility, and contribution to advancing disciplinary knowledge. With 1,673 citations and an h-index of 23, the available bibliometric indicators suggest a sustained level of recognition within the scientific community.[1]

Award Suitability

The International Research Awards on Infectious Diseases recognizes individuals whose scholarly activities contribute to advancing scientific understanding and innovation. Salvatore De Simone’s documented publication record, citation metrics, institutional affiliation, and engagement with vaccine-related research themes align with the objectives commonly associated with academic recognition programs.[3]

Conclusion

Salvatore De Simone represents a research profile characterized by scientific productivity, interdisciplinary collaboration, and measurable scholarly influence. His work contributes to ongoing investigations in infectious diseases and vaccine-related science, including areas associated with pertussis toxin research. Through publications, citations, and continued engagement with biomedical inquiry, his contributions support the advancement of knowledge relevant to public health and scientific innovation.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Salvatore De Simone, Author ID 7003443244. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003443244
  2. ORCID. (n.d.). ORCID profile of Salvatore De Simone. ORCID Registry.
    https://orcid.org/0000-0002-2172-656X
  3. Rangel, K., Chagas, T. P. G., & De-Simone, S. G. (n.d.). Acinetobacter baumannii infections in times of COVID-19 pandemic.
    https://www.mdpi.com/2076-0817/12/1/41
  4. De-Simone, S. G., Lechuga, G. C., Napoleão-Pêgo, P., Freitas, M. S., & Cardozo, S. V. (n.d.). Screening epitopes through comparative analysis of children and mice immune responses to pertussis toxin subunits (S1–S5) induced by whole-cell pertussis vaccination.
    https://www.mdpi.com/2076-393X/14/5/413

Wafa Tombari | Vaccines | Best Researcher Award

Assist. Prof. Dr. Wafa Tombari | Vaccines | Best Researcher Award

Assistant Professor | University Hospital of Sahloul | Tunisia

Dr. Wafa Tombari, Ph.D., is an accomplished Assistant Professor and Research Scientist at the University Hospital of Sahloul, Sousse, specializing in infectious diseases with a focus on virology, vaccine development, and antimicrobial resistance. She holds a Doctoral Diploma in Biology from the Faculty of Sciences in Tunisia, a Master of Science in Microbiology, and a Certificate of Complementary Studies in Statistics and Epidemiological Methods from the Faculty of Medicine in Tunisia. With a distinguished academic and research career, Dr. Tombari has served as an Assistant Professor at both the High Institute of Medical Technologies and the University Hospital of Sahloul, where she has successfully led and collaborated on numerous national and international research projects. Her research integrates molecular biology, bioinformatics, and immunoinformatics to develop computational approaches for vaccine design, antiviral therapeutics, and the study of bacterial resistance mechanisms. She has authored several peer-reviewed publications in reputable international journals, including studies on mRNA-based vaccines for rabies virus and molecular characterization of antimicrobial resistance in Staphylococcus species, highlighting her contributions to advancing biomedical innovation. Beyond her research, Dr. Tombari plays an active role in student mentorship, curriculum development, and scientific outreach, fostering collaboration and innovation within the academic community. Her expertise extends to reverse vaccinology, molecular cloning, and phylogenetic analysis, reflecting her multidisciplinary approach to infectious disease research. Dr. Tombari’s scholarly achievements and professional dedication exemplify her commitment to advancing global health through science and education. She has achieved 119 citations, published 10 scientific documents, and holds an h-index of 5, reflecting her academic influence and research excellence.

Profiles: Scopus | Google Scholar

Featured Publications

1. Tombari, W., Nsiri, J., Larbi, I., Guerin, J. L., & Ghram, A. (2011). Genetic evolution of low pathogenicity H9N2 avian influenza viruses in Tunisia: . Acquisition of new mutations. Virology Journal, 8(1), 467.

2. Tombari, W., Paul, M., Bettaieb, J., Larbi, I., Nsiri, J., Elbehi, I., Gribaa, L., & Ghram, A. (2013). Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia. PLoS ONE, 8(1), e53524.

3. Boudaoud, A., Mamache, B., Tombari, W., & Ghram, A. (2016). Virus mutations and their impact on vaccination against infectious bursal disease (Gumboro disease). Revue Scientifique et Technique, 35(3), 875–897.

4. Kallel Sellami, M., Zitouni, M., Tombari, W., Ben Ayed, M., Abida, O., Laadhar, L., et al. (2007). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. British Journal of Dermatology, 156(3), 591–593.